SOM BIOTECH OBTAINS THE APPROVAL FROM REGULATORY AUTHORITIES TO CARRY OUT THE PHASE IIA CLINICAL TRIAL FOR TTR AMYLOIDOSIS
SOM Biotech has just obtained the approval from the Ethics Committee of Hopital Vall d’Hebron […]
Continue Reading
SOM Biotech has just obtained the approval from the Ethics Committee of Hopital Vall d’Hebron […]
Continue Reading